Senate clears way for von Eschenbach vote

Share this article:
The US Senate today voted to end debate on the nomination of Andrew von Eschenbach to permanently head the FDA, clearing the way for a final vote. Von Eschenbach supporters overcame objections from three Republican senators who opposed his nomination. In a procedural move, the Senate voted, 89-6, to end debate over the nomination. A Senate vote to confirm von Eschenbach as FDA commissioner was expected later today, Reuters reported. Von Eschenbach has served as acting FDA commissioner since September 2005. He was nominated earlier this year by President Bush to take the job permanently.
Share this article:

Email Newsletters

More in News

House bill would speed approval once EU OKs same product

House bill would speed approval once EU OKs ...

The Speeding Access to Already Approved Pharmaceuticals Act of 2014 would require FDA to expedite the review of pharmaceuticals that are already approved by the European Union

Rep access continues to shrink

Rep access continues to shrink

Sales reps are experiencing even more limited physician access, according to a report by Chicago consultancy ZS Associates.

Allergan touts reorg, plans to lay off 13% of workforce

Allergan touts reorg, plans to lay off 13% ...

Allergan's second-quarter earnings, and a new round of cuts, are now part of the Botox maker's record as it seeks to remain independent.